Immunovant, Inc.
IMVT
$13.84
-$1.38-9.07%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -45.77% | 75.21% | 69.72% | 68.74% | 59.71% |
| Total Receivables | 116.13% | 32.02% | 193.68% | 521.81% | 46.16% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 89.43% | 64.19% | 38.44% | -7.48% | -10.90% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -41.96% | 74.25% | 68.29% | 64.66% | 56.41% |
|
|
|||||
| Total Current Assets | -41.96% | 74.25% | 68.29% | 64.66% | 56.41% |
| Net Property, Plant & Equipment | 15.52% | -19.82% | -47.72% | -60.47% | -63.21% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -40.83% | 76.57% | 67.89% | 64.19% | 55.94% |
|
|
|||||
| Total Accounts Payable | 406.80% | 175.96% | -58.29% | 428.82% | -72.08% |
| Total Accrued Expenses | 73.84% | 42.77% | 41.43% | 2.17% | 7.05% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -92.48% | -92.35% | -92.49% | -88.24% | -74.61% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -95.71% | -- |
| Total Other Current Liabilities | -- | -- | -- | -95.71% | -- |
| Total Current Liabilities | 112.81% | 65.56% | -12.34% | 12.27% | -22.19% |
|
|
|||||
| Total Current Liabilities | 112.81% | 65.56% | -12.34% | 12.27% | -22.19% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 112.81% | 65.56% | -12.34% | 12.14% | -22.77% |
|
|
|||||
| Common Stock & APIC | 3.70% | 54.60% | 54.93% | 55.34% | 55.43% |
| Retained Earnings | -51.00% | -46.21% | -42.57% | -45.79% | -48.03% |
| Treasury Stock & Other | 513.17% | 272.32% | 212.71% | 123.94% | -143.38% |
| Total Common Equity | -48.09% | 78.33% | 81.64% | 70.42% | 63.82% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -48.09% | 78.33% | 81.64% | 70.42% | 63.82% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -48.09% | 78.33% | 81.64% | 70.42% | 63.82% |
|
|
|||||